Natural Products, Small Molecules, and Genetics in Tuberculosis Drug Development
- 5 April 2008
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (9), 2606-2612
- https://doi.org/10.1021/jm070719i
Abstract
The impact of natural products on the well being of mankind has been enormous, and their study continues to influence research in the fields of chemistry, biology, and ecology. Historically, the majority of our medicines originate from natural products and their synthetic derivatives, many of which have taught us valuable lessons about biology. While advances in synthetic and combinatorial chemistry have given rise to notable successes in the development of new drugs, the perceived value of natural products has not waned when it comes to treating infectious diseases. In this Miniperspective, we review the role natural products have played in the treatment of tuberculosis (TBa), their value and limitations as chemical probes, the challenges associated with TB drug development, and the current status of natural product and synthetic small molecules as new TB drug leads.Keywords
This publication has 66 references indexed in Scilit:
- Identification of gene targets against dormant phase Mycobacterium tuberculosis infectionsBMC Infectious Diseases, 2007
- OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In MicePLoS Medicine, 2006
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosisPLoS Computational Biology, 2006
- New drug candidates and therapeutic targets for tuberculosis therapyDrug Discovery Today, 2006
- RifamycinMode of Action, Resistance, and BiosynthesisChemical Reviews, 2005
- Massive gene decay in the leprosy bacillusNature, 2001
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Microbial natural products: Alive and well in 1998Nature Biotechnology, 1998
- HISTORICAL BACKGROUNDAnnals of the New York Academy of Sciences, 1960